ARIEL HELLER: Open Payments
NPI 1427554922 · WESTWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$314 in 13 payments from 9 companies in 2025. Trend: 2023 $575 · 2024 $217 · 2025 $314
Food & beverage: $314
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. | 1 | $113 |
| Axsome Therapeutics, Inc. | 3 | $53 |
| ABBVIE INC. | 2 | $34 |
| Teva Pharmaceuticals USA, Inc. | 2 | $29 |
| Lundbeck LLC | 1 | $19 |
| ACADIA Pharmaceuticals Inc | 1 | $18 |
| Almatica Pharma LLC | 1 | $16 |
| Neurocrine BioSciences, Inc. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: Ocrevus Zunovo, VRAYLAR, REXULTI, Auvelity, Sunosi, NUPLAZID, LOREEV XR, INGREZZA.
Industry payments across NJ — which companies pay providers there.
